Transcept Pharmaceuticals' Series B Round

Transcept Pharmaceuticals raised a round of funding on July 11, 2003.

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuros…

Articles about Transcept Pharmaceuticals' Series B Round: